XVALO.MCXVALO.MCBME
Loading
EBITDA Over TimeStable
Percentile Rank33
3Y CAGR-13.6%
5Y CAGR-7.3%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
-13.6%/yr
Annual compound
5Y CAGR
-7.3%/yr
Recent deceleration
Percentile
P33
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive growthStable
PeriodValueYoY Change
2025$14.36B+29.7%
2024$11.07B-37.2%
2023$17.64B-20.7%
2022$22.25B-34.8%
2021$34.13B+62.8%
2020$20.96B+259.1%
2019$5.84B-